Cuprina Holdings (Cayman) LTDCUPR
Price (close)
$1.87
Market cap
$13.1M
P/E
—
Revenue (FY)
$49,894
Net income
-$4.7M
Dividend yield
—
1-year total return
-77.1%
Net margin
-9366.8%
Revenue growth
3.3%
Debt / equity
0.03x
What Cuprina Holdings (Cayman) LTD does.
are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products
for the management of chronic wounds, as well as operating in the health and beauty sector. Our expertise in biomedical research allows
us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $56,599 | $100,773 | $48,321 | $49,894 |
| Net income | — | -$1.1M | -$1.1M | -$1.6M | -$4.7M |
| Free cash flow | — | -$1.9M | -$962,958 | -$1.3M | -$9.2M |
More on CUPR.
- Cuprina Holdings (Cayman) LTD summary
- Cuprina Holdings (Cayman) LTD financial statements
- Cuprina Holdings (Cayman) LTD key metrics
- Cuprina Holdings (Cayman) LTD health scores and style box
- Cuprina Holdings (Cayman) LTD earnings
- Cuprina Holdings (Cayman) LTD dividends
- Cuprina Holdings (Cayman) LTD valuation
- Cuprina Holdings (Cayman) LTD ownership and insiders
- Cuprina Holdings (Cayman) LTD peers
Figures from Cuprina Holdings (Cayman) LTD's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.